ICON Profit Margin 2011-2025 | ICLR
Current and historical gross margin, operating margin and net profit margin for ICON (ICLR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ICON net profit margin as of September 30, 2025 is 7.4%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.638B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $155.708B | 28.59 |
| HCA Healthcare (HCA) | United States | $108.871B | 18.02 |
| CVS Health (CVS) | United States | $99.536B | 11.45 |
| Elevance Health (ELV) | United States | $73.541B | 10.79 |
| Cencora (COR) | United States | $70.765B | 22.83 |
| Natera (NTRA) | United States | $28.437B | 0.00 |
| DiDi Global (DIDIY) | China | $22.826B | 18.65 |
| Labcorp Holdings (LH) | United States | $21.668B | 16.52 |
| Medpace Holdings (MEDP) | United States | $16.500B | 40.96 |
| BioMerieux (BMXMF) | France | $14.511B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.409B | 0.00 |
| Solventum (SOLV) | United States | $13.215B | 12.83 |
| Viatris (VTRS) | United States | $12.278B | 4.58 |
| CochLear (CHEOY) | Australia | $11.483B | 0.00 |
| Revvity (RVTY) | United States | $10.324B | 19.01 |
| HealthEquity (HQY) | United States | $8.630B | 34.54 |
| Charles River Laboratories (CRL) | United States | $8.009B | 15.43 |
| Avantor (AVTR) | United States | $7.418B | 11.33 |
| Sonic Healthcare (SKHHY) | Australia | $6.697B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.690B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.656B | 33.72 |
| Bausch + Lomb (BLCO) | Canada | $5.313B | 34.88 |
| Sotera Health (SHC) | United States | $4.335B | 20.90 |
| GeneDx Holdings (WGS) | United States | $3.745B | 65.76 |
| Amplifon S.p.A (AMFPF) | Italy | $3.560B | 20.77 |
| Alignment Healthcare (ALHC) | United States | $3.209B | 0.00 |
| Concentras Parent (CON) | United States | $2.466B | 15.39 |
| PACS (PACS) | United States | $2.393B | 0.00 |
| Premier (PINC) | United States | $2.327B | 22.55 |
| Progyny (PGNY) | United States | $2.312B | 45.46 |
| Organon (OGN) | United States | $1.989B | 2.10 |
| Pediatrix Medical (MD) | United States | $1.977B | 11.81 |
| Surgery Partners (SGRY) | United States | $1.948B | 25.10 |
| Establishment Labs Holdings (ESTA) | United States | $1.913B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.198B | 0.00 |
| Ardent Health (ARDT) | United States | $1.186B | 3.87 |
| Omada Health (OMDA) | $1.127B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $0.967B | 15.83 |
| Embecta (EMBC) | United States | $0.837B | 4.90 |
| CareDx (CDNA) | United States | $0.798B | 13.03 |
| InnovAge Holding (INNV) | United States | $0.674B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.611B | 8.41 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.577B | 8.74 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.512B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Pomdoctor - (POM) | China | $0.438B | 0.00 |
| CryoPort (CYRX) | United States | $0.426B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 18.16 |
| Auna S.A (AUNA) | Luxembourg | $0.370B | 5.56 |
| Strata Critical Medical (SRTA) | United States | $0.364B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| So-Young (SY) | China | $0.338B | 0.00 |
| SBC Medicals (SBC) | United States | $0.315B | 5.73 |
| Shoulder Innovations (SI) | United States | $0.298B | 0.00 |
| KindlyMD (NAKA) | United States | $0.243B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| Agilon Health (AGL) | United States | $0.223B | 0.00 |
| Beauty Health (SKIN) | United States | $0.162B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.159B | 33.37 |
| Sera Prognostics (SERA) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| DocGo (DCGO) | United States | $0.094B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.024B | 7.28 |
| Basel Medical Group (BMGL) | Singapore | $0.021B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |